Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
17 studies found for:    AREDS2
Show Display Options
Rank Status Study
1 Completed
Has Results
Age-Related Eye Disease Study 2 (AREDS2)
Conditions: Age-related Macular Degeneration;   Cataract
Interventions: Dietary Supplement: Lutein/zeaxanthin;   Dietary Supplement: DHA/EPA;   Drug: Lutein/zeaxanthin and DHA/EPA
2 Completed HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device
Condition: Age Related Macular Degeneration
Intervention: Device: ForeseeHome
3 Active, not recruiting AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
Condition: Age Related Macular Degeneration
4 Completed Blood and Saliva Sample Collection for AREDS 2
Conditions: Age-Related Macular Degeneration;   Eye Diseases
5 Completed
Has Results
Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
Condition: Exudative Age-related Macular Degeneration.
Interventions: Dietary Supplement: Anti-VEGF plus AREDS-2;   Dietary Supplement: Anti-VEGF plus AREDS-1
6 Completed Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study
Conditions: AMD;   Age- Related Macular Degeneration
7 Recruiting Age-Related Eye Disease Study (AREDS) Follow-Up
Conditions: Age-Related Macular Degeneration;   Cataract
8 Active, not recruiting Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention: Dietary Supplement: Omega-3 fatty acid
9 Recruiting Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
Conditions: Age Related Macular Degeneration;   Glaucoma;   Diabetic Retinopathy.
10 Unknown  Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)
Condition: Age-related Macular Degeneration
Interventions: Behavioral: VMS diary booklet;   Behavioral: Standard of Care
11 Recruiting Intervention Trial in Early Age-related Macular Degeneration
Condition: Age-related Macular Degeneration (AMD)
Intervention: Dietary Supplement: Lutein-enriched-egg beverage
12 Recruiting Development of a Device to Measure Dark Adaptation
Conditions: Macular Degeneration;   Age-Related Macular Degeneration
13 Recruiting The Impact of Ocular Diseases on Driving: a Prospective Study
Conditions: Macular Degeneration;   Glaucoma
Interventions: Other: Speed discrimination test;   Behavioral: Driving simulation
14 Completed Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation
Condition: Macular Degeneration
Intervention: Dietary Supplement: Antioxidant
15 Completed Superoxide Dismutase (SOD) as Antioxidant Treatment OF Age Related Macular Degeneration (ARMD)
Condition: Age Related Macular Degeneration
Interventions: Dietary Supplement: SOD;   Dietary Supplement: Sham
16 Not yet recruiting Risk Factors for Drusen Progression
Condition: Age-related Macular Degeneration
17 Completed Antioxidant Systems and Age-Related Macular Degeneration
Condition: Macular Degeneration

Indicates status has not been verified in more than two years